Researchers have developed a new neuroimaging method to track neurodegeneration in Alzheimer's disease. The method helped uncover a new pathway for how degeneration spreads from one brain region to another.
Researchers have developed new neural implants that enable targeted delivery of drugs deep into brain structures.
A new study reports people who have a family history of alcohol use disorder release more dopamine in the ventral striatum as a response to the expectation of receiving an alcoholic drink than those without a family history of alcoholism.
Vascular risk factors appear to have a negative synergistic effect with amyloid beta levels in the brain, researchers report. The study suggests a combination of increased vascular risk and higher amyloid levels in the brain can predict more rapid cognitive decline during aging.
A new study reveals a link between chronic sciatica and inflammation in key areas of the nervous system. Researchers say the location of the inflammation could help to determine which patients will feel relief from steroid injections to curb the pain.
A new study reveals sleep deprivation can lead to an immediate increase in amyloid beta.
Researchers have developed a new blood test capable of detecting biomarkers of Alzheimer's disease long before the first symptoms appear.
Researchers have developed a new imaging agent, which uses PET scans to target receptors neurons implicated in memory and learning.
Researchers propose a new approach to neuroimaging studies. They suggest, rather than beginning with predefined behavioral functions and trying to assign associated brain regions, new studies should focus on selecting brain areas first and screen for potential behavioral associations.
A new study reports those who suffer from persistent depression lasting more than ten years have higher levels of neuroinflammation.
Deep brain stimulation to the frontal lobe may help to improve cognitive, behavioral and functional difficulties in those with Alzheimer's disease, a new study reports.
According to researchers, circadian disruptions can occur years before symptoms of Alzheimer's develop. The findings could help to identify those at risk of developing the neurodegenerative disease as they age.
